Health Trials

Clinical trials

2

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

A Study of CAR-GPRC5D in Patients With Relapsed/Refractory Multiple Myeloma or Plasma Cell Leukemia

This study is a single-center, open-label, dose-exploration study to observe the safety and efficacy of different doses of CAR-GPRC5D in patients with R/R MM or plasma cell leukemia.

Participants needed: 18
Trial details
Phase: Phase 1Age: 18-75Biological sex: AllType: InterventionalSponsor: Chunrui LiUpdated: Jun 11, 2025Locations: 1
Eligibility criteria

age 18 to 75 years old, male or female. [+12]

Subjects who are known to have GVHD or need long-term immunosuppressive therapy. [+17]

Read more
Status: Recruiting

A Study of ESO-T01 in Treating Relapsed/ Refractory Multiple Myeloma

This is a single center, single arm, open-label, dose-escalation clinical study to observe the safety, tolerability, preliminary efficacy, pharmacokinetics, pharmacodynamics of ESO-T01 injection for treating patients with relapsed/refractory multiple myeloma.

Participants needed: 24
Trial details
Phase: Early Phase 1Age: 18+Biological sex: AllType: InterventionalSponsor: Chunrui LiUpdated: Feb 11, 2025Locations: 1
Eligibility criteria

Age ≥ 18 years； [+13]

Previous anticancer treatment (as determined by the investigator): a. Received t... [+13]

Read more